Relapses increase post Tysabri

Another study finds that stopping natalizumab (Tysabri) or switching to another disease modifying drug led to an increased risk of relapses. 2 Minute Medicine Natalizumab (Tysabri) - A to Z of MS
Source: Multiple Sclerosis Trust - Category: Neurology Source Type: news